Endothelial Small- and Intermediate-Conductance K Channels and Endothelium-Dependent Hyperpolarization as Drug Targets in Cardiovascular Disease
- 1 January 2016
- book chapter
- Published by Elsevier
- Vol. 77, 65-104
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- Identification of the functional binding pocket for compounds targeting small-conductance Ca2+-activated potassium channelsNature Communications, 2012
- The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion StrokeJournal of Cerebral Blood Flow & Metabolism, 2011
- Endothelium-derived Vasoactive Factors and Hypertension: Possible Roles in Pathogenesis and as Treatment TargetsCurrent Hypertension Reports, 2010
- Endothelial dysfunction and blood pressure alterations in K+-channel transgenic micePflügers Archiv - European Journal of Physiology, 2010
- Common variants in KCNN3 are associated with lone atrial fibrillationNature Genetics, 2010
- Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K + channel KCa3.1Proceedings of the National Academy of Sciences, 2008
- Calcium-activated potassium channels contribute to human skeletal muscle microvascular endothelial dysfunction related to cardiopulmonary bypassSurgery, 2008
- Effects of methyl β‐cyclodextrin on EDHF responses in pig and rat arteries; association between SKCa channels and caveolin‐rich domainsBritish Journal of Pharmacology, 2007
- Mitogenic modulation of Ca 2+ ‐activated K + channels in proliferating A7r5 vascular smooth muscle cellsBritish Journal of Pharmacology, 2006
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980